Cited by

• Characterization of an herpes simplex virus type 2 mutant, which is resistant to acycloguanosine and causes fusion of BSC1 cells.

  Katz E, Margalith E. Katz E, et al. Arch Virol. 1982;74(2-3):111-23. doi: 10.1007/BF01314705. Arch Virol. 1982. PMID: 6299232
• Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma.

  Caruso M, Pham-Nguyen K, Kwong YL, Xu B, Kosai KI, Finegold M, Woo SL, Chen SH. Caruso M, et al. Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11302-6. doi: 10.1073/pnas.93.21.11302. Proc Natl Acad Sci U S A. 1996. PMID: 8876130 Free PMC article.
• Fertile homozygous transgenic mice expressing a functional truncated herpes simplex thymidine kinase delta TK gene.

  Cohen JL, Boyer O, Salomon B, Onclerco R, Depetris D, Lejeune L, Dubus-Bonnet V, Bruel S, Charlotte F, Mattéï MG, Klatzmann D. Cohen JL, et al. Transgenic Res. 1998 Sep;7(5):321-30. doi: 10.1023/a:1008893206208. Transgenic Res. 1998. PMID: 9859221
• Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir.

  Suzutani T, Ishioka K, De Clercq E, Ishibashi K, Kaneko H, Kira T, Hashimoto K, Ogasawara M, Ohtani K, Wakamiya N, Saijo M. Suzutani T, et al. Antimicrob Agents Chemother. 2003 May;47(5):1707-13. doi: 10.1128/AAC.47.5.1707-1713.2003. Antimicrob Agents Chemother. 2003. PMID: 12709344 Free PMC article.
• Pancreatic carcinoma cell killing via adenoviral mediated delivery of the herpes simplex virus thymidine kinase gene.

  Rosenfeld ME, Vickers SM, Raben D, Wang M, Sampson L, Feng M, Jaffee E, Curiel DT. Rosenfeld ME, et al. Ann Surg. 1997 May;225(5):609-18; discussion 618-20. doi: 10.1097/00000658-199705000-00017. Ann Surg. 1997. PMID: 9193188 Free PMC article.